Patent assignee · KR · COMPANY

ABL BIO INC.

15Patents
15Active
15Granted
47Portfolio score

Filing activity: Jul 2, 2013 → Aug 12, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US10184010B2 Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof Physics 4 Active
US9598483B2 Monoclonal antibody binding specifically to DLL4 and use thereof Physics 3 Active
US10071170B2 Antibody-drug conjugate having improved stability and use thereof Chemistry; Metallurgy 3 Active
US11707533B2 Antibody-drug conjugate comprising antibody against human ROR1 and use for the same Chemistry; Metallurgy 2 Active
US11891445B1 Anti-B7-H3 antibody and use thereof Physics 1 Active
US12173070B2 Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12195537B2 Anti-4-1BB antibody and use thereof Chemistry; Metallurgy 0 Active
US12122830B1 Anti-ROR1 antibody and use thereof Physics 0 Active
US12252541B2 Anti-BCMA antibody and use thereof Chemistry; Metallurgy 0 Active
US12195538B2 Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12049493B2 Anti-alpha-synuclein antibodies and uses thereof Physics 0 Active
US11261259B2 Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12071483B1 Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereof Chemistry; Metallurgy 0 Active
US12168690B2 Anti-EGFR/anti-4-1BB bispecific antibody Chemistry; Metallurgy 0 Active
US12240913B2 Anti-HER2/anti-4-1BB bispecific antibody and use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.